Bharat Biotech's typhoid vaccine gets WHO prequalification Ruby Khatun Khatun5 Jan 2018 10:15 AM ISTNew Delhi: The World Health Organization (WHO) has given its nod to Bharat Biotech's typhoid vaccine Typbar TCV, which has longer-lasting immunity...
Philippines fines Sanofi, suspends clearance for Dengvaxia Ruby Khatun Khatun5 Jan 2018 10:00 AM ISTMANILA: The Philippines has suspended clearance for Sanofi's dengue vaccine Dengvaxia and fined the French drugmaker a symbolic $2,000 citing...
Dr Reddy's drops 4 percent as Duvvada facility receives EIR Ruby Khatun Khatun4 Jan 2018 11:08 AM ISTNew Delhi: Shares of Dr Reddy's Laboratories fell over 4 percent in Wednesday's trade amid reports that an establishment inspection report (EIR) has...
Hetero launches biosimilar Adalimumab in India Ruby Khatun Khatun4 Jan 2018 10:45 AM ISTNew Delhi: Drug firm Hetero said it has launched its biosimilar Adalimumab, used for the treatment of rheumatoid arthritis and other auto-immune...
Spark to charge 850,000 dollars per patient for blindness gene therapy Ruby Khatun Khatun4 Jan 2018 10:30 AM ISTSpark Therapeutics Inc said it will charge $850,000 per patient for its breakthrough gene therapy to treat a rare form of blindness, a lower than the...
FDA warning letter to German drugmaker for Baddi plant Ruby Khatun Khatun4 Jan 2018 10:22 AM ISTNew Delhi: US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing facility...
Novartis breast cancer therapy gets FDA breakthrough designation Ruby Khatun Khatun4 Jan 2018 10:00 AM ISTZURICH: Novartis’s Kisqali (ribociclib) has won U.S. Food and Drug Administration breakthrough therapy designation for treating some breast cancer...
Momenta, Mylan plan trial of biosimilar to Regeneron eye drug Ruby Khatun Khatun4 Jan 2018 9:30 AM ISTMomenta Pharmaceuticals Inc and Mylan NV plan to begin a pivotal clinical trial of a biosimilar to Regeneron Pharmaceuticals Inc’s blockbuster eye...
PMBJPs generic drugs upto 96 percent cheaper than branded equivalents Ruby Khatun Khatun3 Jan 2018 12:30 PM ISTNew Delhi: The government is selling generic medicines at prices cheaper by up to 96 percent compared to their branded generic equivalents through its...
Elite Pharmaceuticals gets FDA approval for Phendimetrazine Tartrate tablets Ruby Khatun Khatun3 Jan 2018 10:05 AM ISTNORTHVALE: Elite Pharmaceuticals announced that it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food...
Johnson and Johnson heart device recalled: USFDA Ruby Khatun Khatun3 Jan 2018 10:00 AM ISTThe U.S. Food and Drug Administration on Tuesday issued a recall of a heart device made by a unit of Johnson & Johnson due to a faulty valve.The...
New drug approvals in 2017 hits 21 year high Ruby Khatun Khatun3 Jan 2018 9:45 AM ISTLONDON: U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light more than double the previous year while the...
